ecrin-mdr-crcClinical2017Cancer; including Breast, Ovarian, Colorectal, Metastatic colorectal(those investigated as part of previous trials using Enadenotucirev).Cáncer; Incluyendo cáncer de mama, ovárico, colorrectal, colorectal metastásico (los investigados como parte de ensayos previos utilizando Enadenotucirev).Cancer; Including Breast, Ovarian, Colorectal, Metastatic Colorectal(those Investigated As Part Of Previous Trials Using Enadenotucirev).Cáncer; Incluyendo Cáncer De Mama, Ovárico, Colorrectal, Colorectal Metastásico (los Investigados Como Parte De Ensayos Previos Utilizando Enadenotucirev).Interventionalhttps://newmdr.ecrin.org/Study/2536439BelgiumUnited StatesUnited KingdomSpain6EnadenotucirevECRIN MDRCompletedfalseA multicentre observational study for the long term follow up of subjects that have been treated with enadenotucirev during interventional clinical trialPrimary objectives: To follow up subjects that have received enadenotucirev during a clinical trial to assess their long term well-being2017-06-1525364392016-004777-40